At the outbreak of Covid-19 the BRC refocused its work and resources on tackling the virus.

UCLH paused all trials unless they were related to Covid-19, or where the treatment involved was essential for serious or life-threatening conditions. This meant the halted trials could no longer screen or recruit patients.

As the pandemic recedes, UCLH is restarting paused trials to ensure ground-breaking research continues and that all the input of patients into trials is not lost.

This page will provide news and updates on studies and access to guidance for researchers and patients.

View facts and figures about UCLH and Covid-19 research.

Vaccine alternative photo cropped_0.jpeg

New target for Covid-19 vaccines identified

Next generation vaccines for Covid-19 should aim to induce an immune response against ‘replication proteins’, essential for the very earliest stages of the viral cycle, according to new UCL research.